Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Refine Biology

Request full access

Biotechnology firm that engages in research, development, and manufacturing of natural food ingredients

Dongcheng District, ChinaFounded 2007Biotech & Life Sciences

About Refine Biology

Beijing Refine Biology Co., Ltd. operates as a supplier of natural, healthy food ingredients, providing comprehensive solutions to the food, beverage, and nutrition industries. The company's business is structured around three main product platforms: a natural sweetener platform known as Refine Zero, a botanical extract platform called Refine Natural, and a natural color platform, Refine NaColor. These platforms deliver a range of products, including sweeteners designed to mimic the taste of sucrose with reduced or zero sugar, various botanical extracts for functional demands like immune support and weight management, and coloring foods that provide natural color solutions.

The company serves customers across the entire value chain, from ingredients to consumer solutions and food service applications. Its operational infrastructure includes three production bases located in Yangling, Chuzhou, and Qufu, which handle the local manufacturing of its products. These facilities adhere to HACCP and GMP standards and have received FSSC22000, ISO9001, HALAL, and KOSHER certifications. To support its product development, Refine Biology maintains two innovation and research and development labs in Beijing and Shanghai. A significant milestone for the company was being granted the status of a National High and New Technology Enterprise in China in 2020.

Refine Biology's product portfolio under the Refine Natural brand includes extracts from sources such as Rhodiola Rosea, Ginger, Milk Thistle, and Turmeric, which are produced using high-tech extraction technology. Another key offering is D-Mannose, which supports urinary tract health. The company is focused on providing turnkey solutions, which involves developing customized options to meet specific client requirements for appearance, taste, function, and nutrition.

Source: Dealroom company data

At a glance

Status
Operational
Employees
35
Open positions
None listed
Dealroom signal
43.4/100
Industry
Health, Food
Sub-industry
BioTechnology, Innovative Food
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2025 $14M $55M Xi'an Royal-Power Asset Management · Xingxiang Capital ↗
SERIES BEquity / VC Oct 2021 $14M $55M Xingnaher Capital · Cowin Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Refine Biology website traffic

Latest recorded traffic for Refine Biology is 260 monthly website visits, up 85.7% over the last three months. Refine Biology's team grew 6.1% over the past year.

Latest monthly visits260 3-month web change+85.7% 1-year team growth+6.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Refine Biology in the Dongcheng District ecosystem

Live from Dealroom

The Refine Biology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Challenjers
  • Xingnaher Capital
  • Cowin Capital

Series B and later2 investors entered at this stage

  • Xingxiang Capital
  • Xi'an Royal-Power Asset Management
Employees 35 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Refine Biology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Refine Biology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.